#1 All Natural Blood Pressure Medicine
Powered by MaxBlogPress  

Posts Tagged ‘Patients’


 Powered by Max Banner Ads 

New Data Confirm Superior Blood Pressure Reductions in Diabetic Patients Treated with TWYNSTA Compared to Amlodipine …
INGELHEIM, Germany–(BUSINESS WIRE)–For NON-US and NON-UK Healthcare Media Only New data show that TWYNSTA , a once daily, single pill combination of the angiotensin II receptor blocker (ARB) telmisartan and the calcium channel blocker (CCB) amlodipine, leads to prompt and very effective reductions in blood pressure in hypertensive patients with diabetes. The results from the TEAMSTA Diabetes …

Read more on Business Wire


Relevant Resources


    If you want to claim CME credit for this presentation, you must view this at webcme.mc.duke.edu Endocrinology Conference presented by Michael S. Kerzner, DPM Clinical Associate in the Department of Surgery, DUMC and hosted by Diana McNeill, MD

    Relevant Resources


    Video with before and after pictures of Lap-Band patients, with the amount of weight lost for each patient. Visit www.AlbanyWeightLoss.com or call 229-434-4200 for more information.

    Relevant Resources

    Study Sheds Light On Why Some Heart Patients With Blocked Arteries Suffer Symptoms While Others With Similarly …
    Research presented at SNM’s 57th Annual Meeting is challenging the typical paradigm used to determine whether heart patients will benefit from invasive procedures like stent-placement or open-heart surgery. Current medical practice favors treating patients with coronary atherosclerosis (or hardening of the artery walls due to plaque build-up) with such procedures if a coronary artery is shown to …

    Read more on Medical News Today


    Relevant Resources

    Phase 3 Study Presented at World Ophthalmology Congress Evaluates Investigational Use of Macugen in Patients With …
    PALM BEACH GARDENS, FL–(Marketwire – 06/05/10) – Eyetech Inc. announced that positive results from a Phase 3 study of Macugen (pegaptanib sodium) in patients with diabetic macular edema (DME) were presented today at the World Ophthalmology Congress in Berlin. In the primary efficacy endpoint of the study, 37% of patients treated with Macugen gained two lines, or 10 letters, of vision on the …

    Read more on Marketwire via Yahoo! Finance


    Relevant Resources

    Record Users, Replay Movies, See Heatmaps of Website Behavior

    Powered by Yahoo! Answers